$86.26 (0.689%)

Volume: 4.036M

Closed: Nov 25, 2022

Hollow Logo Score: 0.000

Gilead Stock Forecast

$86.26 (0.689%)

Volume: 4.036M

Closed: Nov 25, 2022

Score Hollow Logo 0.000

Gilead Stock Statistics NASDAQ:GILD

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-10-04 - 2022-11-25 BUY 32.08
2022-10-03 - 2022-10-04 HOLD 4.80
2022-09-29 - 2022-10-03 SELL -1.19
2022-09-27 - 2022-09-29 HOLD 0.703
2022-09-21 - 2022-09-27 SELL -1.37

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Gilead Sciences

Gilead Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT